Background: Neurodegenerative diseases require characterization based on underlying biology using biochemical biomarkers. Mixed pathology complicates discovery of biomarkers and characterization of cohorts, but inclusion of greater numbers of patients with different, related diseases with frequently co-occurring pathology could allow better accuracy. Combining cohorts collected from different studies would be a more efficient use of resources than recruiting subjects from each population of interest for each study.
Objective: To explore the possibility of combining existing datasets by controlling pre-analytic variables in the Alzheimer's Disease Neuroimaging Initiative (ADNI) and Parkinson's Progression Markers Initiative (PPMI) studies.
Methods: Cerebrospinal fluid (CSF) was collected and processed from 30 subjects according to both the ADNI and PPMI protocols. Relationships between reported levels of Alzheimer's disease (AD) and Parkinson's disease (PD) biomarkers in the same subject under each protocol were examined.
Results: Protocol-related differences were observed for Aβ, but not t-tau or α-syn, and trended different for p-tau and pS129. Values of α-syn differed by platform. Conversion of α-syn values between ADNI and PPMI platforms did not completely eliminate differences in distribution.
Discussion: Factors not captured in the pre-analytical sample handling influence reported biomarker values. Assay standardization and better harmonized characterization of cohorts should be included in future studies of CSF biomarkers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513710 | PMC |
| http://dx.doi.org/10.3233/JAD-190069 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Objective: To investigate hippocampal volume changes in moderate to severe traumatic brain injury (TBI) patients compared to healthy controls and assess their association with post-traumatic epilepsy (PTE), focusing on age-related effects.
Methods: Imaging and demographic data for TBI patients were obtained from the Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) database; healthy controls matched by age and sex were sourced from Alzheimer's Disease Neuroimaging Initiative (ADNI), the National Institute of Mental Health (NIMH) Intramural Healthy Volunteer Dataset, the Parkinson's Progression Markers Initiative (PPMI), and the Autism Brain Imaging Data Exchange (ABIDE). MRI images for TBI subjects were obtained within 14-32 days post-injury.
TGNet: tensor-based graph convolutional networks for multimodal brain network analysis.
BioData Min
December 2024
Department of Computer Science and Engineering, Lehigh University, 113 Research Drive, Bethlehem, 18015, PA, USA.
Article Synopsis
- The paper discusses a new approach called TGNet, a tensor-based graph convolutional network, designed to analyze multimodal brain networks more effectively than current methods.
- TGNet combines tensor decomposition with multi-layer graph convolutional networks to capture both simple and complex brain network structures.
- The framework has been tested on data from various neurological disorders and shows improved accuracy in disease classification, especially when sample sizes are small, showcasing its potential for future research.
Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging.
medRxiv
October 2024
Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, 20892, USA.
Background: Alzheimer's disease and related dementias (ADRD) and Parkinson's disease (PD) are the most common neurodegenerative conditions. These central nervous system disorders impact both the structure and function of the brain and may lead to imaging changes that precede symptoms. Patients with ADRD or PD have long asymptomatic phases that exhibit significant heterogeneity.
View Article and Find Full Text PDFAn efficient ranking-based ensembled multiclassifier for neurodegenerative diseases classification using deep learning.
J Neural Transm (Vienna)
January 2025
Department of Computer Science and Engineering, Thapar Institute of Engineering and Technology, Patiala, Punjab, 147001, India.
Neurodegenerative diseases are group of debilitating and progressive disorders that primarily affect the structure and functions of nervous system, leading to gradual loss of neurons and subsequent decline in cognitive, and behavioral activities. The two frequent diseases affecting the world's significant population falling in the above category are Alzheimer's disease (AD) and Parkinson's disease (PD). These disorders substantially impact the quality of life and burden healthcare systems and society.
View Article and Find Full Text PDFFine hippocampal morphology analysis with a multi-dataset cross-sectional study on 2911 subjects.
Neuroimage Clin
September 2024
School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, China; Shenzhen Key Laboratory of Precision Medicine for Hematological Malignancies, Shenzhen, China; Marshall Laboratory of Biomedical Engineering, Shenzhen University, Shenzhen, China. Electronic address:
CA1 subfield and subiculum of the hippocampus contain a series of dentate bulges, which are also called hippocampus dentation (HD). There have been several studies demonstrating an association between HD and brain disorders. Such as the number of hippocampal dentation correlates with temporal lobe epilepsy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!